Vor Biopharma
VOR
VOR
58 hedge funds and large institutions have $400M invested in Vor Biopharma in 2022 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 26 increasing their positions, 6 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
58
Holders Change
+10
Holders Change %
+20.83%
% of All Funds
0.94%
Holding in Top 10
6
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+100%
% of All Funds
0.1%
New
15
Increased
26
Reduced
6
Closed
5
Calls
$217K
Puts
$42K
Net Calls
+$175K
Net Calls Change
+$164K
Top Buyers
Top Sellers
| 1 |
1
BlackRock
New York
|
$1.58M |
| 2 |
ABG
2
Ally Bridge Group
New York
|
$0 |
| 3 |
E
3
Ergoteles
New York
|
$152K |
| 4 |
TRCT
4
Tower Research Capital (TRC)
New York
|
$172K |
| 5 |
5
Goldman Sachs
New York
|
$0 |
